Download PDF
J Neurol Surg A Cent Eur Neurosurg 2023; 84(03): 255-260
DOI: 10.1055/s-0041-1741546
Original Article

Shunt Dependence after Intraventricular Hemorrhage and Intraventricular Fibrinolysis with uPA versus rt-PA

Raul-Ciprian Covrig
1   Department of Neurosurgery, Johannes Wesling Hospital Minden, Minden, Germany
,
Peter D. Schellinger
2   Department of Neurology, Johannes Wesling Hospital Minden, Minden, Nordrhein-Westfalen, Germany
,
Joerg Glahn
2   Department of Neurology, Johannes Wesling Hospital Minden, Minden, Nordrhein-Westfalen, Germany
,
Ali Alomari
1   Department of Neurosurgery, Johannes Wesling Hospital Minden, Minden, Germany
,
Kirsten Schmieder
3   Department of Neurosurgery, Knappschafts-Krankenhaus Bochum Langendreer, Bochum, Germany
,
M. Wiese
3   Department of Neurosurgery, Knappschafts-Krankenhaus Bochum Langendreer, Bochum, Germany
,
Ulrich Johannes Knappe
1   Department of Neurosurgery, Johannes Wesling Hospital Minden, Minden, Germany
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Background We compare the effect of urokinase (urokinase-type plasminogen activator [uPA]) versus alteplase (recombinant tissue plasminogen activator [rt-PA]) for intraventricular fibrinolysis (IVF) in patients with intraventricular hemorrhage (IVH) on ventriculoperitoneal shunt (VPS) dependence, functional outcome, and complications in the management of IVH.

Methods We retrospectively reviewed the patients admitted with IVH or intracerebral hemorrhage (ICH) with IVH within 7 years in three different departments and found 102 patients who met the inclusion criteria. The primary end points were VPS dependence and Glasgow outcome score (GOS) at 3 months. Secondary end points were rate of rebleeding under IVF and incidence of treatment-related complications. Patients were divided into three groups: group I comprised patients treated with external ventricular drain (EVD) and IVF with uPA; group II comprised patients treated with EVD and IVF with rt-PA; and group III comprised patients treated with EVD alone.

Results In all, 9.8% patients needed VPS: 12.2% in group I and 15.0% in group II, with no statistically significant difference. VPS patients had higher values of the modified Graeb score (mGS), IVH score, and IVH volume. We saw a trend for a better outcome in group II, with six patients achieving a GOS of 4 or 5 after 3 months. The mortality rate was higher in groups I and III. We found no statistical difference in the complication rate between groups I and II. Logistic regression analysis revealed that higher mGS and age predicted worse prognosis concerning mortality. The risk for death rose by 7.8% for each year of age. Any additional mGS point increased the chances of death by 9.7%.

Conclusion Our data suggest that both uPA and rt-PA are safe and comparable regarding incidence of communicating hydrocephalus, and age and mGS are predictive for mortality.

Keywords

intraventricular fibrinolysis - shunt dependence - uPA - rt-PA - intraventricular hemorrhage


Publication History

Received: 01 February 2021

Accepted: 08 November 2021

Article published online:
31 January 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Labovitz DL, Halim A, Boden-Albala B, Hauser WA, Sacco RL. The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics. Neurology 2005; 65 (04) 518-522
    CrossrefPubMedSearch in Google Scholar
  • 2 Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med 2001; 344 (19) 1450-1460
    CrossrefPubMedSearch in Google Scholar
  • 3 Sudlow CL, Warlow CP. International Stroke Incidence Collaboration. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. Stroke 1997; 28 (03) 491-499
    CrossrefPubMedSearch in Google Scholar
  • 4 Daverat P, Castel JP, Dartigues JF, Orgogozo JM. Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke 1991; 22 (01) 1-6
    CrossrefPubMedSearch in Google Scholar
  • 5 Bhattathiri PS, Gregson B, Prasad KS, Mendelow AD. STICH Investigators. Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the STICH trial. Acta Neurochir Suppl (Wien) 2006; 96: 65-68
    CrossrefPubMedSearch in Google Scholar
  • 6 Hallevi H, Albright KC, Aronowski J. et al. Intraventricular hemorrhage: anatomic relationships and clinical implications. Neurology 2008; 70 (11) 848-852
    CrossrefPubMedSearch in Google Scholar
  • 7 Steiner T, Diringer MN, Schneider D. et al. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery 2006; 59 (04) 767-773 , discussion 773–774
    CrossrefPubMedSearch in Google Scholar
  • 8 Mayer SA, Brun NC, Begtrup K. et al; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 352 (08) 777-785
    CrossrefPubMedSearch in Google Scholar
  • 9 Mayer SA, Brun NC, Begtrup K. et al; FAST Trial Investigators. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008; 358 (20) 2127-2137
    CrossrefPubMedSearch in Google Scholar
  • 10 Mendelow AD, Gregson BA, Fernandes HM. et al; STICH investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005; 365 (9457): 387-397
    CrossrefPubMedSearch in Google Scholar
  • 11 Gaberel T, Magheru C, Parienti JJ, Huttner HB, Vivien D, Emery E. Intraventricular fibrinolysis versus external ventricular drainage alone in intraventricular hemorrhage: a meta-analysis. Stroke 2011; 42 (10) 2776-2781
    CrossrefPubMedSearch in Google Scholar
  • 12 Pang D, Sclabassi RJ, Horton JA. Lysis of intraventricular blood clot with urokinase in a canine model: Part 3. Effects of intraventricular urokinase on clot lysis and posthemorrhagic hydrocephalus. Neurosurgery 1986; 19 (04) 553-572
    CrossrefPubMedSearch in Google Scholar
  • 13 Findlay JM, Jacka MJ. Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage. Neurosurgery 2004; 55 (03) 532-537 , discussion 537–538
    CrossrefPubMedSearch in Google Scholar
  • 14 Shen PH, Matsuoka Y, Kawajiri K. et al. Treatment of intraventricular hemorrhage using urokinase. Neurol Med Chir (Tokyo) 1990; 30 (05) 329-333
    CrossrefPubMedSearch in Google Scholar
  • 15 Mayfrank L, Lippitz B, Groth M, Bertalanffy H, Gilsbach JM. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage. Acta Neurochir (Wien) 1993; 122 (1–2): 32-38
    CrossrefPubMedSearch in Google Scholar
  • 16 Rainov NG, Burkert WL. Urokinase infusion for severe intraventricular haemorrhage. Acta Neurochir (Wien) 1995; 134 (1-2): 55-59
    CrossrefPubMedSearch in Google Scholar
  • 17 Huttner HB, Tognoni E, Bardutzky J. et al. Influence of intraventricular fibrinolytic therapy with rt-PA on the long-term outcome of treated patients with spontaneous basal ganglia hemorrhage: a case-control study. Eur J Neurol 2008; 15 (04) 342-349
    CrossrefPubMedSearch in Google Scholar
  • 18 Khan NR, Tsivgoulis G, Lee SL. et al. Fibrinolysis for intraventricular hemorrhage: an updated meta-analysis and systematic review of the literature. Stroke 2014; 45 (09) 2662-2669
    CrossrefPubMedSearch in Google Scholar
  • 19 Naff N, Williams MA, Keyl PM. et al. Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke 2011; 42 (11) 3009-3016
    CrossrefPubMedSearch in Google Scholar
  • 20 Murthy SB, Awad I, Harnof S. et al; CLEAR III Trial Investigators. Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial. Neurology 2017; 89 (04) 355-362
    CrossrefPubMedSearch in Google Scholar
  • 21 Hallevi H, Dar NS, Barreto AD. et al. The IVH score: a novel tool for estimating intraventricular hemorrhage volume: clinical and research implications. Crit Care Med 2009; 37 (03) 969-974, e1
    CrossrefPubMedSearch in Google Scholar
  • 22 Lapointe M, Haines S. Fibrinolytic therapy for intraventricular hemorrhage in adults. Cochrane Database Syst Rev 2002; 3 (03) CD003692
    PubMedSearch in Google Scholar
  • 23 Naff NJ, Hanley DF, Keyl PM. et al. Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery 2004; 54 (03) 577-583 , discussion 583–584
    CrossrefPubMedSearch in Google Scholar
  • 24 Staykov D, Huttner HB, Lunkenheimer J. et al. Single versus bilateral external ventricular drainage for intraventricular fibrinolysis in severe ventricular haemorrhage. J Neurol Neurosurg Psychiatry 2010; 81 (01) 105-108
    CrossrefPubMedSearch in Google Scholar
  • 25 Wang D, Liu J, Norton C, Liu M, Selim M. Local fibrinolytic therapy for intraventricular hemorrhage: a meta-analysis of randomized controlled trials. World Neurosurg 2017; 107: 1016-1024.e1
    CrossrefPubMedSearch in Google Scholar
  • 26 Coplin WM, Vinas FC, Agris JM. et al. A cohort study of the safety and feasibility of intraventricular urokinase for nonaneurysmal spontaneous intraventricular hemorrhage. Stroke 1998; 29 (08) 1573-1579
    CrossrefPubMedSearch in Google Scholar
  • 27 Staykov D, Bardutzky J, Huttner HB, Schwab S. Intraventricular fibrinolysis for intracerebral hemorrhage with severe ventricular involvement. Neurocrit Care 2011; 15 (01) 194-209
    CrossrefPubMedSearch in Google Scholar
  • 28 Staykov D, Kuramatsu JB, Bardutzky J. et al. Efficacy and safety of combined intraventricular fibrinolysis with lumbar drainage for prevention of permanent shunt dependency after intracerebral hemorrhage with severe ventricular involvement: a randomized trial and individual patient data meta-analysis. Ann Neurol 2017; 81 (01) 93-103
    CrossrefPubMedSearch in Google Scholar
  • 29 Appelboom G, Piazza MA, Hwang BY. et al. Severity of intraventricular extension correlates with level of admission glucose after intracerebral hemorrhage. Stroke 2011; 42 (07) 1883-1888
    CrossrefPubMedSearch in Google Scholar
  • 30 Flint AC, Roebken A, Singh V. Primary intraventricular hemorrhage: yield of diagnostic angiography and clinical outcome. Neurocrit Care 2008; 8 (03) 330-336
    CrossrefPubMedSearch in Google Scholar
  • 31 Song P, Duan FL, Cai Q. et al. Endoscopic surgery versus external ventricular drainage surgery for severe intraventricular hemorrhage. Curr Med Sci 2018; 38 (05) 880-887
    CrossrefPubMedSearch in Google Scholar
  • 32 Tuhrim S, Horowitz DR, Sacher M, Godbold JH. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med 1999; 27 (03) 617-621
    CrossrefPubMedSearch in Google Scholar
  • 33 Arboix A, García-Eroles L, Vicens A, Oliveres M, Massons J. Spontaneous primary intraventricular hemorrhage: clinical features and early outcome. ISRN Neurol 2012; 2012: 498303
    CrossrefPubMedSearch in Google Scholar
  • 34 Morgan TC, Dawson J, Spengler D. et al; CLEAR and VISTA Investigators. The Modified Graeb Score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcome. Stroke 2013; 44 (03) 635-641
    CrossrefPubMedSearch in Google Scholar
  • 35 Huttner HB, Schwab S, Bardutzky J. Lumbar drainage for communicating hydrocephalus after ICH with ventricular hemorrhage. Neurocrit Care 2006; 5 (03) 193-196
    CrossrefPubMedSearch in Google Scholar
  • 36 Hanley DF, Lane K, McBee N. et al; CLEAR III Investigators. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet 2017; 389 (10069): 603-611
    CrossrefPubMedSearch in Google Scholar
  • 37 Volbers B, Wagner I, Willfarth W, Doerfler A, Schwab S, Staykov D. Intraventricular fibrinolysis does not increase perihemorrhagic edema after intracerebral hemorrhage. Stroke 2013; 44 (02) 362-366
    CrossrefPubMedSearch in Google Scholar
  • 38 Yadav YR, Mukerji G, Shenoy R, Basoor A, Jain G, Nelson A. Endoscopic management of hypertensive intraventricular haemorrhage with obstructive hydrocephalus. BMC Neurol 2007; 7: 1
    CrossrefPubMedSearch in Google Scholar
  • 39 Basaldella L, Marton E, Fiorindi A, Scarpa B, Badreddine H, Longatti P. External ventricular drainage alone versus endoscopic surgery for severe intraventricular hemorrhage: a comparative retrospective analysis on outcome and shunt dependency. Neurosurg Focus 2012; 32 (04) E4
    CrossrefPubMedSearch in Google Scholar